Escherichia coli K1's capsule is a barrier to bacteriophage T7.
about
Dispersing biofilms with engineered enzymatic bacteriophageAntimicrobial bacteriophage-derived proteins and therapeutic applicationsBattling Phages: How Bacteria Defend against Viral AttackMasquerading microbial pathogens: capsular polysaccharides mimic host-tissue moleculesBacteria vs. Bacteriophages: Parallel Evolution of Immune ArsenalsThe function of integron-associated gene cassettes in Vibrio species: the tip of the icebergHigh-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agentsThe core oligosaccharide and thioredoxin of Vibrio cholerae are necessary for binding and propagation of its typing phage VP3Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesisThe T7-related Pseudomonas putida phage φ15 displays virion-associated biofilm degradation properties.The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli.Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat.Phage-encoded colanic acid-degrading enzyme permits lytic phage infection of a capsule-forming resistant mutant Escherichia coli strainIsolation and Genomic Characterization of the T4-Like Bacteriophage PM2 Infecting Pectobacterium carotovorum subsp. carotovorum.Virulence reduction in bacteriophage resistant bacteria.Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?Phage Therapy - Everything Old is New AgainA multivalent adsorption apparatus explains the broad host range of phage phi92: a comprehensive genomic and structural analysis.Threading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.Polar flagella rotation in Vibrio parahaemolyticus confers resistance to bacteriophage infection.Origins and virulence mechanisms of uropathogenic Escherichia coliPathogen detection using engineered bacteriophages.Phage approved in food, why not as a therapeutic?Dynamics and genetic diversification of Escherichia coli during experimental adaptation to an anaerobic environmentBdellovibrio predation in the presence of decoys: Three-way bacterial interactions revealed by mathematical and experimental analyses.Biofilm control with natural and genetically-modified phages.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages.Function of bacteriophage G7C esterase tailspike in host cell adsorption.Engineering of Bacteriophages Y2::dpoL1-C and Y2::luxAB for Efficient Control and Rapid Detection of the Fire Blight Pathogen, Erwinia amylovora.Genomic analysis of Bacillus subtilis lytic bacteriophage ϕNIT1 capable of obstructing natto fermentation carrying genes for the capsule-lytic soluble enzymes poly-γ-glutamate hydrolase and levanase.Characterization of a novel bacteriophage, Phda1, infecting the histamine-producing Photobacterium damselae subsp. damselae.Proteolytic release of the intramolecular chaperone domain confers processivity to endosialidase F.Evolutionary principles and synthetic biology: avoiding a molecular tragedy of the commons with an engineered phageHost exopolysaccharide quantity and composition impact Erwinia amylovora bacteriophage pathogenesis.The tail-associated depolymerase of Erwinia amylovora phage L1 mediates host cell adsorption and enzymatic capsule removal, which can enhance infection by other phage.Lysogenic conversion and phage resistance development in phage exposed Escherichia coli biofilms.Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan.Ability of phages to infect Acinetobacter calcoaceticus-Acinetobacter baumannii complex species through acquisition of different pectate lyase depolymerase domains.
P2860
Q24684087-7D68528E-1021-4121-9544-916A092C0132Q26781115-069B7D55-CA5A-4FE5-BD23-4023437887A2Q26823132-C8946154-0F4B-4129-B48F-1B7A1EF6A821Q26865784-4D58FC2B-CE71-4A83-B388-49C843D2384DQ28071639-6FEE4522-3824-4918-8E11-4648A3F8D5A0Q28304685-59C9D87D-CD52-462A-ABC8-892425144879Q28474866-507F2B43-2A36-4728-80BE-2907775D4A64Q28487217-0F58EF42-2EDC-43D5-BD90-BF7980F11E84Q28540213-8452FD1A-F3C8-4218-97BB-109B54135BD9Q33883634-262547F9-7A78-4DE6-A679-86E52B646090Q34231078-3573DC56-E1D4-4919-B96E-8F4930F3B048Q34416671-283E16BC-8A72-462A-81E6-38AB6853E35BQ34933801-5D27462E-5F8A-4153-B288-4967720C1D4AQ35168482-9D465D29-D77F-4D1B-A1E2-500149816C7CQ35531270-686341BA-4B3D-4C1C-AB09-A7CD0FD9BD3DQ35539762-C0D027AC-75C5-4247-B80B-B3EC065B00A9Q35853204-A12A09C5-B8FD-46CB-9736-ACA5CCFFEBF8Q36171271-3049A5D5-29E2-4763-B081-154F630D4A5BQ36276483-30A0D6B7-8C84-4A0C-9E89-D351E61555E2Q36705848-C2274924-5CBA-4338-93E2-D2FF729C454EQ36910560-E257BFF4-5A40-44AF-866A-41C0CE54B921Q36998104-F06B0B9A-F1D0-43D8-8BDD-E57FE6102654Q37958647-DDC0C127-4169-40A0-BFA5-5CDA9F792654Q38285489-67ABB35E-0DF3-4E3C-9425-E1945479898FQ38403177-8E6E2B25-C835-4973-AFB3-BA46D56248B3Q38667677-576DBE6B-E8B8-42CF-8532-F26F02500BFCQ38756810-16D3487C-BBC9-4BC6-861B-E9606FC473ECQ39029801-734AA1C5-A8FC-4CEE-ACB1-24A518C2D228Q39083103-58EA1065-12F3-411B-B8DB-39825F1F781FQ40209565-2550E529-BC00-407D-916B-576897B61147Q40252561-3D657F5C-11F3-4D84-95EF-07122DAC1678Q40436301-220A943D-0FDA-400B-8A1A-BA65768E7D08Q41158620-F514C071-C740-40DC-BBA2-E31314961726Q41780441-116F0B20-F060-4C0C-9729-DD03BB5FD00BQ41974764-FEDA7374-8446-4756-AFB8-CBB38F1DF862Q42119430-23426E88-E78A-41FE-9AF5-B4A82ED172B8Q42276803-B3778C0A-0A8D-46DA-89FC-8AC170A10339Q42277772-F7CD65DB-8B7E-4B5C-9D67-9A48730CC975Q45337752-2CBDD967-0465-4807-8074-377B4F96E2CBQ46273435-80063A0B-A2A4-4556-B88A-343B321578E5
P2860
Escherichia coli K1's capsule is a barrier to bacteriophage T7.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Escherichia coli K1's capsule is a barrier to bacteriophage T7.
@ast
Escherichia coli K1's capsule is a barrier to bacteriophage T7.
@en
type
label
Escherichia coli K1's capsule is a barrier to bacteriophage T7.
@ast
Escherichia coli K1's capsule is a barrier to bacteriophage T7.
@en
prefLabel
Escherichia coli K1's capsule is a barrier to bacteriophage T7.
@ast
Escherichia coli K1's capsule is a barrier to bacteriophage T7.
@en
P2093
P2860
P1476
Escherichia coli K1's capsule is a barrier to bacteriophage T7.
@en
P2093
Carl Merril
Dean Scholl
Sankar Adhya
P2860
P304
P356
10.1128/AEM.71.8.4872-4874.2005
P407
P577
2005-08-01T00:00:00Z